Ser1412
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser1412  -  nNOS (mouse)

Site Information
TNRLRSEsIAFIEES   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 449830

In vivo Characterization
Methods used to characterize site in vivo:
phospho-antibody ( 2 , 4 ) , western blotting ( 2 , 4 )
Relevant cell line - cell type - tissue:
kidney ( 2 ) , myocyte-heart ( 4 )

Upstream Regulation
Treatments:
Akt_inhibitor_X ( 4 ) , high-salt diet ( 2 ) , isoproterenol ( 4 )

Downstream Regulation
Effects of modification on nNOS:
activity, induced ( 4 )
Effects of modification on biological processes:
signaling pathway regulation ( 4 )

References 

1

Zhao T, et al. (2021) Hepatic nNOS impaired hepatic insulin sensitivity through the activation of p38 MAPK. J Endocrinol
33434144   Curated Info

2

Zhang J, et al. (2020) New Mechanism for the Sex Differences in Salt-Sensitive Hypertension: The Role of Macula Densa NOS1β-Mediated Tubuloglomerular Feedback. Hypertension 75, 449-457
31865794   Curated Info

3

Wang Z, et al. (2018) Quantitative phosphoproteomic analysis of the molecular substrates of sleep need. Nature 558, 435-439
29899451   Curated Info

4

Curran J, et al. (2014) Nitric Oxide-Dependent Activation of CaMKII Increases Diastolic Sarcoplasmic Reticulum Calcium Release in Cardiac Myocytes in Response to Adrenergic Stimulation. PLoS One 9, e87495
24498331   Curated Info